03/26/2024
3:05 PM | Lexicon Pharmaceuticals (Filer)
| Form ARS | |
03/26/2024
6:05 AM | Lexicon Pharmaceuticals (Filer)
| Form DEF 14A | |
03/26/2024
6:06 AM | Lexicon Pharmaceuticals (Filer)
| Form DEFA14A | |
03/25/2024
3:17 PM | Lexicon Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/13/2024
8:20 PM | Invus, L.P. (Filed by)
Lexicon Pharmaceuticals (Subject)
| Form SC 13D/A | |
03/13/2024
8:22 PM | Artal Group S.A. (Reporting)
Artal International Management S.A. (Reporting)
Artal International S.C.A. (Reporting)
Invus Advisors, L.L.C. (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Invus, L.P. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Stichting Administratiekantoor Westend (Reporting)
Westend S.A. (Reporting)
Wittouck Amaury (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
3:31 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
03/11/2024
6:26 AM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
3:31 PM | Lexicon Pharmaceuticals (Issuer)
McDermott Wendy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:32 PM | Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:33 PM | Alexander Kristen (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
8:37 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Lexicon Pharmaceuticals (Subject)
| Form SC 13G/A | |
12/29/2023
4:27 PM | Lexicon Pharmaceuticals (Filer)
| Form 424B5 | |
12/29/2023
4:29 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/17/2023
3:55 PM | COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
4:31 PM | COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
3:16 PM | Lexicon Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023
6:22 AM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/12/2023
3:01 PM | DEBBANE RAYMOND (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2023
3:06 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2023
3:06 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2023
4:05 PM | Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/04/2023
6:07 AM | Lexicon Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/04/2023
6:09 AM | Lexicon Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/31/2023
3:02 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2023
7:13 AM | Lexicon Pharmaceuticals (Issuer)
Sullivan Diane E. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/31/2023
7:14 AM | Lexicon Pharmaceuticals (Issuer)
Sullivan Diane E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
3:01 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2023
3:34 PM | Lexicon Pharmaceuticals (Subject)
Seth Kiernan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/29/2023
3:13 PM | COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
3:20 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2023
3:22 PM | Lexicon Pharmaceuticals (Issuer)
McDermott Wendy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
3:04 PM | COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:30 PM | Lexicon Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
06/20/2023
3:10 PM | Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
3:46 PM | Artal Group S.A. (Reporting)
Artal International Management S.A. (Reporting)
Artal International S.C.A. (Reporting)
Invus Advisors, L.L.C. (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Invus, L.P. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Stichting Administratiekantoor Westend (Reporting)
Westend S.A. (Reporting)
Wittouck Amaury (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
3:31 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/01/2023
8:08 PM | Lexicon Pharmaceuticals (Filer)
| Form 424B5 | |
06/01/2023
7:12 AM | Lexicon Pharmaceuticals (Subject)
| Form FWP | |
05/31/2023
3:17 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
6:10 AM | Lexicon Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
The “Next Bitcoin”? 10 CENT Crypto Set to Explode (Ad) The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%...
Is now exposing a 10-cent coin that just partnered with Amazon… Click For My #1 FREE Crypto for 2024 |
04/28/2023
3:25 PM | Lexicon Pharmaceuticals (Issuer)
NIES ALAN S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2023
3:26 PM | Lexicon Pharmaceuticals (Issuer)
Palantoni Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
